Cathay Biotech (688065) Stock Price, Fundamentals & Analysis

What 688065 does

Cathay Biotech (688065) is a stock listed on the Shanghai Stock Exchange that researches, develops, produces, and sells bio-based materials. Its portfolio includes biological long-chain diacids such as sebacic acid and octadecanedioic acid, bio-based polyamides, and bio-based pentamethylene diamine sold under the TERRYL and ECOPENT brands. The company also provides digital solutions for electrification, automation, and digitization in biological manufacturing. Cathay Biotech serves end markets including textiles, pharmaceuticals, automobiles, electronic appliances, consumer goods, and engineering materials, and it exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

Key numbers explained

• 38.34 CNY is the current price, the latest traded value of one share.
• -2.49% is today's price change, showing the percentage move relative to the previous close.
• 27.65B CNY is the market capitalization, the total value of all outstanding shares at the current price.
• The trailing P/E ratio of 44.1 divides the current price by the last twelve months of earnings per share (0.87 CNY), a common way to compare how the market prices earnings today.
• The forward P/E ratio of 31.7 uses expected future earnings, which can be lower if analysts forecast growth.
• 1.17% is the dividend yield, the annual dividend per share divided by the current price, indicating the cash return shareholders receive relative to the share price.
• 0.41 is the beta, a measure of how much the stock's price tends to move compared to the broader market; a value below 1 suggests lower volatility.
• 17.7% is the profit margin, showing how much of each yuan of revenue becomes net profit.
• 14.6% is the year-over-year revenue growth, reflecting how quickly top-line sales have expanded recently.

What to watch

Cathay Biotech operates in the Basic Materials sector and Chemicals industry, where commodity price cycles, raw material costs, and global demand for bio-based alternatives can drive share price moves. Investors often track revenue growth and margins to see whether the company is scaling efficiently, while the relatively low beta of 0.41 suggests the stock may be less volatile than the broader market. The ex-dividend date of 29 iul. 2026 is the key date for anyone focused on income, since shares bought after that date will not receive the next dividend payment. Cathay Biotech is part of the Shanghai Stock Exchange ecosystem, where sector peers such as Aluminum Corporation of China Limited (601600), Jiangxi Copper (600362), China Northern Rare Earth Group (600111), ZHEJIANG HUAYOU COBALT (603799), Zhongjin Gold (600489), XinJiang Daqo New Energy (688303), and Ningxia Baofeng Energy Group (600989) can provide context for sector rotation and capital allocation trends. For a broader view of the market, see the Shanghai Stock Exchange stocks page or the full Stocks directory.